NHS: Drugs
Commons · Question 105088 · Tabled 12 Jan 2026 · Department of Health and Social Care · Official record
Answered 22 Jan 2026
Question
Asked by Helen Morgan
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential impact of NHS spending on pharmaceutical products on NHS service provision in the context of the UK-US trade deal.
Answer
Answered by Zubir Ahmed, 22 Jan 2026
By increasing the standard National Institute for Health and Care Excellence (NICE) cost-effectiveness threshold, we are increasing the value that we place on innovations that deliver improvements to patient health. Alongside the changes that we announced...